Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Denmark
  4. Nasdaq Copenhagen
  5. Novozymes A/S
  6. Summary
    NZYM B   DK0060336014

NOVOZYMES A/S

(NZYM B)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Copenhagen
06/17/2021 06/18/2021 06/21/2021 06/22/2021 06/23/2021 Date
459.5(c) 460.4(c) 466.4(c) 469.6(c) 469.3 Last
352 027 659 127 325 554 322 398 23 348 Volume
-0.61% +0.20% +1.30% +0.69% -0.06% Change
More quotes
Estimated financial data (e)
Sales 2021 14 605 M 2 341 M 2 341 M
Net income 2021 3 052 M 489 M 489 M
Net Debt 2021 4 184 M 671 M 671 M
P/E ratio 2021 42,8x
Yield 2021 1,17%
Sales 2022 15 228 M 2 441 M 2 441 M
Net income 2022 3 160 M 507 M 507 M
Net Debt 2022 3 963 M 635 M 635 M
P/E ratio 2022 40,7x
Yield 2022 1,25%
Capitalization 130 B 20 863 M 20 895 M
EV / Sales 2021 9,21x
EV / Sales 2022 8,82x
Nbr of Employees 6 274
Free-Float 71,9%
More Financials
Company
Novozymes A/S is the world's leading producer of enzymes and microorganisms for industrial companies. Net sales break down by market as follows: - industry of cleaning and household maintenance products (34.8%); - food industry and human health (19.8%); - bioenergy (18%); - technical and cereal industries (14.3%): microorganisms used in the field of wastewater treatment, technical enzymes intended for the... 
Read more
Sector
Specialty Chemicals
Calendar
08/12Earnings Release
More about the company
Ratings of Novozymes A/S
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about NOVOZYMES A/S
06/21NOVOZYMES A/S  : Transactions under Novozymes' stock buyback program
AQ
06/14NOVOZYMES A/S  : DSM-Novozymes Alliance launches its second-generation protease,..
PU
06/07NOVOZYMES A/S  : Transactions under Novozymes' stock buyback program
AQ
05/25NOVOZYMES A/S  : honors researchers who have turned research into green business
PU
05/25NOVOZYMES A/S  : Transactions under Novozymes' stock buyback program
AQ
05/10NOVOZYMES A/S  : Transactions under Novozymes' stock buyback program
AQ
05/04TODAY'S ANALYST RECOMMENDATIONS : Dollar General, ENI, Infineon...
05/03NOVOZYMES A/S  : enters partnership with Danish retailer
PU
04/29NOVOZYMES A/S  : Trading by management and close relations of management
AQ
04/29NOVOZYMES A/S  : Professional cleaning companies collaborate to evaluate the ben..
PU
04/27NOVOZYMES A/S  : Maintains FY21 Outlook as Q1 Net Profit Grows 9%
MT
04/27Novozymes delivers solid Q1 results with 3% organic sales growth and strong e..
GL
04/27NOVOZYMES A/S  : Interim report for Q1 2021
AQ
04/27NOVOZYMES A/S  : 1st quarter results
CO
04/26UNIVAR  : Expands Distribution Deal With Novozymes into US, Canadian Food Ingred..
MT
More news
News in other languages on NOVOZYMES A/S
05/04AVIS D'ANALYSTES DU JOUR  : BNP Paribas, Amundi, Sanofi, Schneider, Eramet, Neoe..
05/04STOCK MARKET PARIS : Du rififi chez les Gates
04/28AVIS D'ANALYSTES DU JOUR  : Schneider, bioMérieux, ABB, Nestlé, Porsche, Rectice..
04/27TAGESVORSCHAU : Termine am 27. April 2021
03/04DGAP-HV : Covestro AG: Bekanntmachung der -6-
More news
Analyst Recommendations on NOVOZYMES A/S
More recommendations
Chart NOVOZYMES A/S
Duration : Period :
Novozymes A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVOZYMES A/S
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 18
Last Close Price 469,60 DKK
Average target price 379,53 DKK
Spread / Average Target -19,2%
EPS Revisions
Managers and Directors
NameTitle
Ester Baiget President & Chief Executive Officer
Lars Green Chief Financial Officer & Executive Vice President
Jørgen Buhl Rasmussen Chairman
Claus Crone Fuglsang Chief Scientific Officer & Executive VP
Graziela Chaluppe dos Santos Malucelli Chief Operating Officer & Executive VP
Sector and Competitors
1st jan.Capitalization (M$)
NOVOZYMES A/S34.36%20 863
ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD30.14%6 315
CATHAY BIOTECH INC.9.83%5 800
COFCO BIOTECHNOLOGY CO., LTD.5.94%2 568
BORREGAARD ASA25.95%2 074
HENAN JINDAN LACTIC ACID TECHNOLOGY CO., LTD-9.47%1 617